News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
592,352 Results
Type
Article (47008)
Company Profile (211)
Press Release (545133)
Multimedia
Podcasts (62)
Webinars (11)
Section
Business (164356)
Career Advice (2463)
Deals (29659)
Drug Delivery (110)
Drug Development (76081)
Employer Resources (144)
FDA (14412)
Job Trends (13300)
News (290430)
Policy (29089)
Tag
Academia (2766)
Academic (1)
Accelerated approval (5)
Adcomms (28)
Allergies (82)
Alliances (42573)
ALS (94)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (134)
Approvals (14402)
Artificial intelligence (261)
Autoimmune disease (23)
Automation (16)
Bankruptcy (318)
Best Places to Work (10971)
BIOSECURE Act (21)
Biosimilars (103)
Biotechnology (160)
Bladder cancer (83)
Brain cancer (28)
Breast cancer (271)
Cancer (2243)
Cardiovascular disease (189)
Career advice (2072)
Career pathing (32)
CAR-T (160)
Cell therapy (436)
Cervical cancer (16)
Clinical research (61813)
Collaboration (815)
Company closure (1)
Compensation (381)
Complete response letters (23)
COVID-19 (2573)
CRISPR (45)
C-suite (256)
Cystic fibrosis (97)
Data (2183)
Decentralized trials (2)
Denatured (17)
Depression (52)
Diabetes (273)
Diagnostics (6065)
Digital health (15)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (122)
Drug pricing (113)
Drug shortages (28)
Duchenne muscular dystrophy (91)
Earnings (58979)
Editorial (40)
Employer branding (19)
Employer resources (131)
Events (84904)
Executive appointments (742)
FDA (15629)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (710)
Gene editing (114)
Generative AI (23)
Gene therapy (329)
GLP-1 (765)
Government (4363)
Grass and pollen (5)
Guidances (66)
Healthcare (17568)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (127)
Indications (30)
Infectious disease (2721)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (95)
Interviews (525)
IPO (13628)
IRA (45)
Job creations (2788)
Job search strategy (1701)
Kidney cancer (11)
Labor market (20)
Layoffs (451)
Leadership (23)
Legal (6278)
Liver cancer (76)
Lung cancer (329)
Lymphoma (149)
Machine learning (6)
Management (51)
Manufacturing (290)
MASH (75)
Medical device (11176)
Medtech (11180)
Mergers & acquisitions (16542)
Metabolic disorders (715)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (103)
Neuropsychiatric disorders (32)
Neuroscience (1989)
NextGen: Class of 2025 (5973)
Non-profit (4275)
Now hiring (32)
Obesity (381)
Opinion (233)
Ovarian cancer (72)
Pain (91)
Pancreatic cancer (82)
Parkinson's disease (149)
Partnered (20)
Patents (228)
Patient recruitment (110)
Peanut (43)
People (53939)
Pharmaceutical (48)
Pharmacy benefit managers (14)
Phase I (19051)
Phase II (27119)
Phase III (20697)
Pipeline (1191)
Policy (151)
Postmarket research (2541)
Preclinical (8021)
Press Release (60)
Prostate cancer (108)
Psychedelics (37)
Radiopharmaceuticals (234)
Rare diseases (391)
Real estate (4641)
Recruiting (57)
Regulatory (20556)
Reports (25)
Research institute (2356)
Resumes & cover letters (360)
Rett syndrome (5)
RNA editing (4)
RSV (41)
Schizophrenia (77)
Series A (125)
Series B (83)
Service/supplier (4)
Sickle cell disease (56)
Special edition (12)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3079)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (38)
The Weekly (44)
Vaccines (679)
Venture capitalists (37)
Weight loss (260)
Women's health (32)
Worklife (17)
Date
Today (123)
Last 7 days (812)
Last 30 days (2452)
Last 365 days (30604)
2025 (10080)
2024 (32821)
2023 (36905)
2022 (47622)
2021 (51182)
2020 (49598)
2019 (42808)
2018 (32474)
2017 (29304)
2016 (28027)
2015 (32437)
2014 (24684)
2013 (20497)
2012 (21846)
2011 (22592)
2010 (20098)
Location
Africa (794)
Alabama (55)
Alaska (5)
Arizona (156)
Arkansas (11)
Asia (36402)
Australia (7285)
California (5497)
Canada (1877)
China (498)
Colorado (238)
Connecticut (245)
Delaware (139)
Europe (82204)
Florida (866)
Georgia (181)
Idaho (54)
Illinois (504)
India (24)
Indiana (295)
Iowa (9)
Japan (162)
Kansas (94)
Kentucky (21)
Louisiana (9)
Maine (60)
Maryland (829)
Massachusetts (4130)
Michigan (199)
Minnesota (305)
Mississippi (2)
Missouri (80)
Montana (24)
Nebraska (23)
Nevada (58)
New Hampshire (64)
New Jersey (1632)
New Mexico (25)
New York (1600)
North Carolina (921)
North Dakota (7)
Northern California (2389)
Ohio (174)
Oklahoma (8)
Oregon (29)
Pennsylvania (1237)
Puerto Rico (12)
Rhode Island (31)
South America (1079)
South Carolina (20)
South Dakota (1)
Southern California (2075)
Tennessee (84)
Texas (801)
United States (20951)
Utah (172)
Virginia (147)
Washington D.C. (60)
Washington State (514)
West Virginia (3)
Wisconsin (48)
592,352 Results for "aevi genomic medicine formerly known as medgenics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Press Releases
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Press Releases
Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
April 4, 2025
·
5 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Moss Genomics Launches “Perennial” Genomics Platform, Closes on 130 ETH
April 28, 2025
·
7 min read
Press Releases
Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025
April 10, 2025
·
6 min read
Press Releases
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 2, 2025
·
3 min read
Press Releases
Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform
October 28, 2024
·
3 min read
1 of 59,236
Next
